Option Grant-biOasis Technologies Inc.

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/19/12 -- biOasis Technologies Inc. (TSX VENTURE: BTI) announces that is has granted options to its officers, employees, consultants and members of the board of directors. A total of 1,647,000 options have been granted in accordance with the approved stock option plan, effective at the close of business on July 19, 2012 at a price of $1.28 per share expiring on July 19, 2017. The options shall vest according to the Company's stock option plan.

On Behalf of the Board of Directors

Rob Hutchison, Chairman & CEO

"Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release"



Contacts:
biOasis Technologies Inc.
Rob Hutchison
Chairman & CEO
(778).383.3280

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 19.07.2012 - 22:38 Uhr
Sprache: Deutsch
News-ID 167153
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA

Kategorie:

Medical Devices

Diese Pressemitteilung wurde bisher 313 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Option Grant-biOasis Technologies Inc."
steht unter der journalistisch-redaktionellen Verantwortung von

biOasis Technologies Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

biOasis Announces the Successful Delivery to the CNS of an Enzyme Used to Treat ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/31/15 -- BIOASIS TECHNOLOGIES INC. (OTCQX: BIOAF)(TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain ...

biOasis Technologies Inc. and Brigham and Women's Hospital Inc., Enter a Ne ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/21/15 -- biOasis (OTCQX: BIOAF)(TSX VENTURE: BTI) and Brigham and Women's Hospital Inc. ("BWH"), Harvard Medical School's distinguished teaching hospital, have entered into a co ...

biOasis Engages Kilmer Lucas for Cross-Border Investor Relations ...

RICHMOND, BRITISH COLUMBIA -- (Marketwired) -- 06/08/15 -- BIOASIS TECHNOLOGIES INC. (OTCQX: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain ...

Alle Meldungen von biOasis Technologies Inc.